Whales with a lot of money to spend have taken a noticeably bearish stance on Neumora Therapeutics.
Looking at options history for Neumora Therapeutics NMRA we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $581,375 and 6, calls, for a total amount of $245,900.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $15.0 for Neumora Therapeutics over the last 3 months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Neumora Therapeutics options trades today is 7461.43 with a total volume of 6,284.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Neumora Therapeutics's big money trades within a strike price range of $5.0 to $15.0 over the last 30 days.
Neumora Therapeutics Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NMRA | PUT | TRADE | BEARISH | 01/17/25 | $1.35 | $1.15 | $1.45 | $5.00 | $378.0K | 15.1K | 3.1K |
| NMRA | CALL | SWEEP | BEARISH | 01/17/25 | $4.0 | $3.7 | $3.79 | $12.50 | $77.4K | 7.6K | 246 |
| NMRA | PUT | TRADE | BEARISH | 12/19/25 | $5.7 | $5.0 | $5.5 | $10.00 | $55.0K | 8 | 100 |
| NMRA | PUT | SWEEP | BULLISH | 01/17/25 | $2.4 | $2.25 | $2.25 | $7.50 | $44.4K | 8.2K | 211 |
| NMRA | CALL | TRADE | BEARISH | 01/17/25 | $4.3 | $3.9 | $4.0 | $12.50 | $40.0K | 7.6K | 414 |
About Neumora Therapeutics
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
In light of the recent options history for Neumora Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Neumora Therapeutics's Current Market Status
- Currently trading with a volume of 422,366, the NMRA's price is up by 1.03%, now at $10.74.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 70 days.
What The Experts Say On Neumora Therapeutics
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $30.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Reflecting concerns, an analyst from HC Wainwright & Co. lowers its rating to Buy with a new price target of $30.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Neumora Therapeutics with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
